Artificial intelligence in preventive cardiology
Copyright © 2024. Published by Elsevier Inc..
Artificial intelligence (AI) is a field of study that strives to replicate aspects of human intelligence into machines. Preventive cardiology, a subspeciality of cardiovascular (CV) medicine, aims to target and mitigate known risk factors for CV disease (CVD). AI's integration into preventive cardiology may introduce novel treatment interventions and AI-centered clinician assistive tools to reduce the risk of CVD. AI's role in nutrition, weight loss, physical activity, sleep hygiene, blood pressure, dyslipidemia, smoking, alcohol, recreational drugs, and mental health has been investigated. AI has immense potential to be used for the screening, detection, and monitoring of the mentioned risk factors. However, the current literature must be supplemented with future clinical trials to evaluate the capabilities of AI interventions for preventive cardiology. This review discusses present examples, potentials, and limitations of AI's role for the primary and secondary prevention of CVD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Progress in cardiovascular diseases - (2024) vom: 07. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
El Sherbini, Adham [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 09.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.pcad.2024.03.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369506243 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369506243 | ||
| 003 | DE-627 | ||
| 005 | 20240310232153.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240310s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pcad.2024.03.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1322.xml |
| 035 | |a (DE-627)NLM369506243 | ||
| 035 | |a (NLM)38460897 | ||
| 035 | |a (PII)S0033-0620(24)00038-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a El Sherbini, Adham |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Artificial intelligence in preventive cardiology |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 09.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024. Published by Elsevier Inc. | ||
| 520 | |a Artificial intelligence (AI) is a field of study that strives to replicate aspects of human intelligence into machines. Preventive cardiology, a subspeciality of cardiovascular (CV) medicine, aims to target and mitigate known risk factors for CV disease (CVD). AI's integration into preventive cardiology may introduce novel treatment interventions and AI-centered clinician assistive tools to reduce the risk of CVD. AI's role in nutrition, weight loss, physical activity, sleep hygiene, blood pressure, dyslipidemia, smoking, alcohol, recreational drugs, and mental health has been investigated. AI has immense potential to be used for the screening, detection, and monitoring of the mentioned risk factors. However, the current literature must be supplemented with future clinical trials to evaluate the capabilities of AI interventions for preventive cardiology. This review discusses present examples, potentials, and limitations of AI's role for the primary and secondary prevention of CVD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Alcohol | |
| 650 | 4 | |a Artificial intelligence | |
| 650 | 4 | |a Blood pressure | |
| 650 | 4 | |a Dyslipidemia | |
| 650 | 4 | |a Machine learning | |
| 650 | 4 | |a Mental health | |
| 650 | 4 | |a Nutrition | |
| 650 | 4 | |a Physical activity | |
| 650 | 4 | |a Preventive cardiology | |
| 650 | 4 | |a Recreational drugs | |
| 650 | 4 | |a Sleep hygiene | |
| 650 | 4 | |a Smoking | |
| 650 | 4 | |a Weight loss | |
| 700 | 1 | |a Rosenson, Robert S |e verfasserin |4 aut | |
| 700 | 1 | |a Al Rifai, Mahmoud |e verfasserin |4 aut | |
| 700 | 1 | |a Virk, Hafeez Ul Hassan |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Zhen |e verfasserin |4 aut | |
| 700 | 1 | |a Virani, Salim |e verfasserin |4 aut | |
| 700 | 1 | |a Glicksberg, Benjamin S |e verfasserin |4 aut | |
| 700 | 1 | |a Lavie, Carl J |e verfasserin |4 aut | |
| 700 | 1 | |a Krittanawong, Chayakrit |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Progress in cardiovascular diseases |d 1958 |g (2024) vom: 07. März |w (DE-627)NLM000009903 |x 1873-1740 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:07 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pcad.2024.03.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 07 |c 03 | ||